Nuvalent, Inc. (NUVL)

97.06 -0.37 (-0.38%) USD  |  NASDAQ  |  Mar 19, 16:00
97.99 +0.93 (+0.96%) Pre-Market: 08:33
More

Nuvalent EPS LT Growth Estimates

EPS LT Growth Estimates Chart

View EPS LT Growth Estimates for NUVL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS LT Growth Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS LT Growth Estimates Range, Past 5 Years

View EPS LT Growth Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS LT Growth Estimates Benchmarks

View EPS LT Growth Estimates Benchmarks
Start Trial
Glaukos Corp. Upgrade
Edgewise Therapeutics, Inc. --
Cogent Biosciences, Inc. --
Neurocrine Biosciences, Inc. Upgrade
Vanda Pharmaceuticals, Inc. Upgrade